previous compound ID: 1675 next compound
InChIKey: PCZOHLXUXFIOCF-BXMDZJJMSA-N
SMILES: CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "E Matthes" "J Goepp" "J Liao" "JW Hanrahan" "DY Thomas" "R Robert" "D Rotin" "GW Carlile" "B Kus"

chemical graph of compound 1675





CID is 53232
synonyms found at PubChem are:
lovastatin, 75330-75-5, mevinolin, Mevacor, Monacolin K, Lovalip, Altoprev, Lovalord, Mevinacor, Nergadan, Altocor, Artein, 6alpha-Methylcompactin, MK-803, Hipovastin, Lovastatine, Lovasterol, Cholestra, Closterol, Colevix, Hipolip, Lestatin, Lipivas, Lipofren, Lovastin, Lozutin, Paschol, Rodatin, Rovacor, Tecnolip, Teroltrat, Belvas, Lipdip, Mevlor, Sivlor, Taucor, Lovastatine [French], Lovastatinum [Latin], Lovastatina [Spanish], 6-alpha-Methylcompactin, Lovastatinum, Lovastatina, 6-Methylcompactin, MSD 803, MK 803, Liposcler, 6 alpha-Methylcompactin, Rextat, Monakolin K, UNII-9LHU78OQFD, Mevacor (TN), Lovastatin [USAN:BAN:INN], MLS000069585, Lovastatin & Primycin, HSDB 6534, Lovastatin (USP/INN), 9LHU78OQFD, BRN 3631989, SMR000058779, CHEBI:40303, ML-530B, 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone, C24H36O5, (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, NCGC00023509-03, DSSTox_CID_784, EN300-52515, DSSTox_RID_75788, DSSTox_GSID_20784, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, 1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-, L-154803, Lovastatin (Mevacor), 6 Methylcompactin, butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-, (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate, 74133-25-8, Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, CPD000673570, CHEMBL503, SR-05000001880, (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one, lostatin, CCRIS 8092, 1cqp, Lovastatin,(S), Lovastatin [USAN:USP:INN:BAN], MK803, (+)-mevinolin, Altoprev (TN), Statosan (TN), (S)-((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate, [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, Prestwick_819, Advicor (TN), Altocor (TN), Lovastatin, (1 alpha(S*))-Isomer, CAS-75330-75-5, Lovastatin [USAN], Lovastatin (Mevinolin), Opera_ID_1578, Prestwick0_000516, Prestwick1_000516, Prestwick2_000516, Prestwick3_000516, Spectrum3_001873, Spectrum5_001294, Lovastatin (MK-803), Lovastatin, 97% 5g, D06WTZ, EC 616-212-7, AC1L1EI6, AC1Q2C7T, SCHEMBL3136, US9115116, lovastatin, BIDD:PXR0113, BSPBio_000471, BSPBio_001265, BSPBio_003346, cid_53232, KSC377A8D, MLS001055358, MLS006011867, US9353061, Lovastatina, ARONIS24208, BIDD:GT0749, DivK1c_001032, SPECTRUM1503977, SPBio_002392, Mevinolin from Aspergillus sp., BPBio1_000519, GTPL2739, MEGxm0_000398, DTXSID5020784, SCHEMBL14227102, ACon0_000534, ACon1_000390, BDBM34168, CTK2H7081, HMS503O05, KBio1_001032, KBio3_002848, AOB5269, MolPort-001-739-990, NINDS_001032, PCZOHLXUXFIOCF-BXMDZJJMSA-N, HMS1569H13, HMS1792O07, HMS1923O13, HMS1990O07, HMS2089M06, HMS2093O03, HMS2096H13, HMS2236F07, HMS3039N16, HMS3259F10, HMS3268C03, HMS3403O07, HMS3713H13, Pharmakon1600-01503977, (S)-((1S,3R,7S,8S,8AR)-8-(2-((2R,4R)-4-HYDROXY-6-OXO-TETRAHYDRO-2H-PYRAN-2-YL)ETHYL)-3,7-DIMETHYL-1,2,3,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL) 2-METHYLBUTANOATE, 2-Methyl-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester butanoic acid, ACT02620, ALBB-027272, BB_NC-01457, Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-, HY-N0504, ZINC3812841, Tox21_110888, Tox21_201475, Tox21_300268, ANW-41686, BBL024473, BG0243, CCG-39627, MFCD00072164, NSC633781, NSC758662, s2061, SBB080686, STK801953, AKOS005267139, Tox21_110888_1, CS-1990, DB00227, EBD2126857, KS-1082, MCULE-4740518260, MCULE-7087866108, Mevinolin from Aspergillus sp., powder, NC00713, NSC-633781, NSC-758662, RTR-031803, IDI1_001032, NCGC00023509-04, NCGC00023509-05, NCGC00023509-06, NCGC00023509-07, NCGC00023509-08, NCGC00023509-09, NCGC00023509-10, NCGC00023509-11, NCGC00023509-13, NCGC00023509-14, NCGC00023509-16, NCGC00254157-01, NCGC00259026-01, AC-13961, CC-30040, CC-30041, CJ-10768, G226, LS-46359, SAM002589904, SAM002589963, SC-11968, SMR000673570, SBI-0051881.P002, AB0108514, L0214, N1632, C07074, D00359, J10136, S-7779, 28048-EP2269989A1, 28048-EP2270011A1, 28048-EP2272825A2, 28048-EP2272841A1, 28048-EP2277507A1, 28048-EP2277865A1, 28048-EP2280006A1, 28048-EP2281813A1, 28048-EP2284158A1, 28048-EP2286795A1, 28048-EP2287165A2, 28048-EP2287166A2, 28048-EP2289892A1, 28048-EP2292620A2, 28048-EP2295406A1, 28048-EP2295409A1, 28048-EP2298742A1, 28048-EP2298745A1, 28048-EP2298772A1, 28048-EP2298776A1, 28048-EP2298779A1, 28048-EP2301923A1, 28048-EP2301931A1, 28048-EP2301936A1, 28048-EP2305648A1, 28048-EP2308839A1, 28048-EP2311808A1, 28048-EP2311829A1, 28048-EP2314588A1, 96638-EP2287163A1, 96638-EP2305678A1, AB00052400-17, AB00052400_18, AB00052400_19, Mevinolin from Aspergillus sp., >=98% (HPLC), 117141-EP2272825A2, 117141-EP2298776A1, 330L755, A838030, C-21799, SR-01000000123, I06-1876, SR-01000000123-3, SR-05000001880-1, SR-05000001880-2, BRD-K09416995-001-06-8, BRD-K09416995-001-21-7, Lovastatin, 1 alpha-Isomer (without R*/S* notation), Z1258578375, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat, (2S)-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl-2-methyl butanoate, (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester, (S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester, [(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate, 1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate, 71949-96-7, 8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl (2S)-2-methylbutanoate, 81739-26-6, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-, Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha-(R*),3-alpha,7-beta,8-beta-(2S*,4S*),8a-beta))-, Butanoic acid, 2-methyl-,1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester,(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))